Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Medical Marijuana Inc MJNA

Healthcare
Medical Marijuana, Inc. manufactures and distributes natural health, beauty and hemp-derived cannabidiol (CBD) products through e-commerce, direct sales, retail and wholesale distribution channels. It operates in three divisions. Medical Marijuana, Inc. division operates its Website to maintain an online presence, provide corporate, investor relations and educational information and news... see more

Recent & Breaking News (OTCPK:MJNA)

Increasing Jobs in the Legal Cannabis Market

PR Newswire March 15, 2017

Medical Marijuana, Inc. Welcomes New Sales Manager Eric Raszewski to Subsidiary HempMeds® Team

PR Newswire March 15, 2017

Study Results: Medical Marijuana, Inc. Subsidiary HempMeds® Mexico Announces Release Of Study Using Its Real Scientific Hemp Oil-X™ To Treat Epileptic Children

Canada NewsWire March 14, 2017

Sessions' Recent Comments Highlights the Importance of Cannabis Diversification -- CFN Media

Marketwired March 9, 2017

Dope Magazine Features Medical Marijuana, Inc. Subsidiary HempMeds® Mexico In Historic 'Look At America's Reverse-Cannabis Pipeline'

PR Newswire March 8, 2017

Medical Marijuana, Inc. Investment AXIM® Biotech Announces Enrolled Patients Begin Phase II Trial For The Treatment Of Irritable Bowel Syndrome (IBS) With CanChew Plus® Cannabidiol (CBD) Chewing Gum

Canada NewsWire March 7, 2017

Medical Marijuana, Inc. CEO Featured Speaker at California Cannabis Business Expo, Change.org Petition Seeks to Engage Trump Administration

PR Newswire March 6, 2017

Medical Marijuana Inc.'s RSHO Approved in Brazil for Autism -- CFN Media

Marketwired March 2, 2017

Medical Marijuana, Inc. Clarifies Operations Unaffected by White House Statements Hinting at Recreational Marijuana Crackdown

PR Newswire March 1, 2017

'Greater Enforcement' of Federal Laws Would Have Mixed Impact in Cannabis Industry

PR Newswire March 1, 2017

Medical Marijuana, Inc. CEO Covered by National Mexico Media Outlets Discussing Landmark Firsts, CBD Market at A4M Mexico

PR Newswire February 28, 2017

Autism Approval: Medical Marijuana, Inc. Subsidiary HempMeds® Brasil Receives Brazilian Government Permission for Import of Flagship Product RSHO™

PR Newswire February 28, 2017

Cannabis CBD Infused Products Grow in Popularity Along With Newest Medicinal Applications and Uses

PR Newswire Europe Non Regulatory February 28, 2017

Dr. Stuart Titus, Chief Executive Officer of Medical Marijuana, Inc., Discusses Recent News and Events in a New Audio Interview at SmallCapVoice.com

GlobeNewswire February 27, 2017

Cannabis Products are Becoming More Acceptable

PR Newswire February 23, 2017

The Tangential Opportunities of the Cannabis Industry

PR Newswire February 22, 2017

Multiple Sclerosis Approval: Medical Marijuana, Inc. Subsidiary HempMeds® Brasil Receives Brazilian Government Permission for Import of Flagship Product RSHO™

PR Newswire February 21, 2017

FinancialBuzz.com: Cannabis Market Brings in Significant Tax Revenues

PR Newswire February 21, 2017

Multiple Sclerosis Receives Brazilian Government Permission to be Treated with HempMeds® Brasil, Flagship Product RSHO™

PR Newswire February 21, 2017

Medical Marijuana, Inc. Subsidiary, HempMeds Brasil Featured in 'Veja' Article Highlighting Brazilian Health Authority Approval of RSHO™ on Patients with Alzheimer's Disease

PR Newswire February 15, 2017